ArticleOPEN ACCESS

Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis

American Journal of Hematology
DOI: 10.1002/ajh.27505
8Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Kaulen, L. D., Karschnia, P., Doubrovinskaia, S., Abramson, J. S., Martinez-Lage, M., Shankar, G., … Dietrich, J. (2024, December 1). Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. American Journal of Hematology. John Wiley and Sons Inc. https://doi.org/10.1002/ajh.27505

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free